Anti-HtrA2 / Omi antibody [E55]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(18 Publications)
Rabbit Recombinant Monoclonal HtrA2 / Omi antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 18 publications.
View Alternative Names
OMI, PRSS25, HTRA2, High temperature requirement protein A2, Omi stress-regulated endoprotease, Serine protease 25, Serine proteinase OMI, HtrA2
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HtrA2 / Omi antibody [E55] (AB32092)
ab32092 at a 1 : 250 dilution staining Htr2A/ Omi in human lung adenocarcinoma using Immunohistochemistry Paraffin Embedded Tissue.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-HtrA2 / Omi antibody [E55] (AB32092)
All lanes:
Western blot - Anti-HtrA2 / Omi antibody [E55] (ab32092) at 1/2000 dilution
All lanes:
Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate
Predicted band size: 49 kDa
Observed band size: 38 kDa
false
Related conjugates and formulations (1)
-
Anti-HtrA2 / Omi antibody [E55] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The degradation and signaling processes of HtrA2/Omi protect against proteotoxic stress. It operates within the mitochondria and under stress conditions relocates to the cytosol where it can influence apoptosis. HtrA2/Omi can interact with inhibitors of apoptosis proteins (IAPs) and by doing this promotes apoptosis when necessary. This regulation of cell death links HtrA2/Omi to the cellular quality control mechanisms directly impacting cell survival and health.
Pathways
HtrA2/Omi integrates into the mitochondrial apoptosis pathway and is important in Parkinson's disease pathways. Through its interactions with apoptosis regulators like XIAP HtrA2/Omi facilitates the removal of unwanted cells. Additionally it participates in signaling pathways involving caspases and other pro-apoptotic factors. Its activity ensures proper communication and response within these pathways to maintain cellular balance and respond to stressors or damage.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (18)
Recent publications for all applications. Explore the full list and refine your search
Heliyon 9:e14039 PubMed36915530
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 8:218 PubMed35449197
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 22:3127-3134 PubMed32945404
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of molecular histology 50:405-415 PubMed31256303
2019
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicine & pharmacotherapy = Biomedecine & phar 114:108844 PubMed30981108
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell stress & chaperones 24:91-104 PubMed30374881
2018
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 18:165 PubMed30377412
2018
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 18:2973-2986 PubMed30015897
2018
Applications
Unspecified application
Species
Unspecified reactive species
Toxicology research 7:792-808 PubMed30310657
2018
Applications
Unspecified application
Species
Unspecified reactive species
Cellular & molecular biology letters 23:14 PubMed29636771
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com